Xiaoyin Ke

488 total citations
16 papers, 356 citations indexed

About

Xiaoyin Ke is a scholar working on Cognitive Neuroscience, Pharmacology and Biological Psychiatry. According to data from OpenAlex, Xiaoyin Ke has authored 16 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cognitive Neuroscience, 7 papers in Pharmacology and 7 papers in Biological Psychiatry. Recurrent topics in Xiaoyin Ke's work include Tryptophan and brain disorders (7 papers), Treatment of Major Depression (7 papers) and Autism Spectrum Disorder Research (4 papers). Xiaoyin Ke is often cited by papers focused on Tryptophan and brain disorders (7 papers), Treatment of Major Depression (7 papers) and Autism Spectrum Disorder Research (4 papers). Xiaoyin Ke collaborates with scholars based in China, United States and Australia. Xiaoyin Ke's co-authors include Yuping Ning, Ke Xu, Ni Fan, Daping Wang, Wei Zheng, Qing Dai, Xuefeng Deng, Hongbo He, Chao Zhou and Haiyan Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Annals of the New York Academy of Sciences.

In The Last Decade

Xiaoyin Ke

15 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoyin Ke China 11 112 109 96 69 64 16 356
Madeeha Nasir United States 8 98 0.9× 86 0.8× 118 1.2× 110 1.6× 52 0.8× 13 397
Raz Levin Israel 8 103 0.9× 131 1.2× 73 0.8× 40 0.6× 116 1.8× 14 364
Nariko Katayama Japan 6 88 0.8× 110 1.0× 99 1.0× 26 0.4× 63 1.0× 12 312
Olrik von Widdern Germany 8 106 0.9× 129 1.2× 128 1.3× 101 1.5× 127 2.0× 11 568
Agnese Marsano Italy 7 82 0.7× 80 0.7× 37 0.4× 66 1.0× 33 0.5× 10 294
Mikael Tiger Sweden 13 159 1.4× 85 0.8× 116 1.2× 61 0.9× 161 2.5× 31 464
Vibeke H. Dam Denmark 12 106 0.9× 62 0.6× 135 1.4× 39 0.6× 43 0.7× 36 320
David R. Latov United States 5 203 1.8× 165 1.5× 142 1.5× 35 0.5× 118 1.8× 6 448
Hannah Gola Germany 7 133 1.2× 141 1.3× 65 0.7× 210 3.0× 62 1.0× 7 592
Charli Randolph United States 3 161 1.4× 96 0.9× 59 0.6× 137 2.0× 41 0.6× 5 392

Countries citing papers authored by Xiaoyin Ke

Since Specialization
Citations

This map shows the geographic impact of Xiaoyin Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyin Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyin Ke more than expected).

Fields of papers citing papers by Xiaoyin Ke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyin Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyin Ke. The network helps show where Xiaoyin Ke may publish in the future.

Co-authorship network of co-authors of Xiaoyin Ke

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyin Ke. A scholar is included among the top collaborators of Xiaoyin Ke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyin Ke. Xiaoyin Ke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Han, Chuanliang, Xiaoyin Ke, Meijia Li, et al.. (2022). Oscillatory biomarkers of autism: evidence from the innate visual fear evoking paradigm. Cognitive Neurodynamics. 17(2). 459–466. 22 indexed citations
2.
Liang, Yujie, Xiaoyin Ke, Zhou Xiao, et al.. (2020). Untargeted Metabolomic Profiling Using UHPLC‐QTOF/MS Reveals Metabolic Alterations Associated with Autism. BioMed Research International. 2020(1). 6105608–6105608. 19 indexed citations
3.
Liang, Yujie, Hong Yu, Xiaoyin Ke, et al.. (2020). Vitamin D deficiency worsens maternal diabetes induced neurodevelopmental disorder by potentiating hyperglycemia‐mediated epigenetic changes. Annals of the New York Academy of Sciences. 1491(1). 74–88. 21 indexed citations
4.
Liang, Yujie, Zhou Xiao, Xiaoyin Ke, et al.. (2020). Urinary Metabonomic Profiling Discriminates Between Children with Autism and Their Healthy Siblings. Medical Science Monitor. 26. e926634–e926634. 15 indexed citations
5.
Ke, Xiaoyin, Haiyan Li, Qing Dai, et al.. (2019). Prevalence and risk factors for depression in outpatient departments of three general hospitals in China: a cross-sectional study. International Journal of Psychiatry in Clinical Practice. 24(1). 88–95. 5 indexed citations
6.
Zheng, Wei, Haiyan Li, Xiaoyin Ke, et al.. (2018). Prevalence of insomnia symptoms and their associated factors in patients treated in outpatient clinics of four general hospitals in Guangzhou, China. BMC Psychiatry. 18(1). 232–232. 21 indexed citations
7.
Ke, Xiaoyin, Yi� Ding, Ke Xu, et al.. (2018). The profile of cognitive impairments in chronic ketamine users. Psychiatry Research. 266. 124–131. 42 indexed citations
8.
Zheng, Wei, Haiyan Li, Xiaoyin Ke, et al.. (2018). Regional differences in the risk of insomnia symptoms among patients from general hospital outpatient clinics. Neuropsychiatric Disease and Treatment. Volume 14. 3307–3315. 6 indexed citations
9.
Li, Haiyan, Xiaoyin Ke, Qing Dai, et al.. (2017). Major depressive disorder and suicide risk among adult outpatients at several general hospitals in a Chinese Han population. PLoS ONE. 12(10). e0186143–e0186143. 72 indexed citations
11.
Fan, Ni, Ke Xu, Yuping Ning, et al.. (2016). Profiling the psychotic, depressive and anxiety symptoms in chronic ketamine users. Psychiatry Research. 237. 311–315. 31 indexed citations
12.
Fan, Ni, Yayan Luo, Ke Xu, et al.. (2015). Relationship of serum levels of TNF-α, IL-6 and IL-18 and schizophrenia-like symptoms in chronic ketamine abusers. Schizophrenia Research. 169(1-3). 10–15. 15 indexed citations
13.
Fan, Ni, Min-Ling Zhang, Ke Xu, et al.. (2015). Serum level of vascular endothelial growth factor decreased in chronic ketamine abusers. Drug and Alcohol Dependence. 152. 57–61. 9 indexed citations
14.
Fan, Ni, Ke Xu, Yuping Ning, et al.. (2015). Development of a checklist of short-term and long-term psychological symptoms associated with ketamine use.. PubMed. 27(3). 186–94. 6 indexed citations
15.
Xu, Ke, John H. Krystal, Yuping Ning, et al.. (2014). Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia. Journal of Psychiatric Research. 61. 64–72. 46 indexed citations
16.
Ke, Xiaoyin, Yi Ding, Ke Xu, et al.. (2014). Serum brain-derived neurotrophic factor and nerve growth factor decreased in chronic ketamine abusers. Drug and Alcohol Dependence. 142. 290–294. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026